Literature DB >> 21601903

Retinal vein occlusion: beyond the acute event.

Justis P Ehlers1, Sharon Fekrat.   

Abstract

Retinal vein occlusion is a major cause of vision loss. We provide an overview of the clinical features, pathogenesis, natural history, and management of both branch retinal vein occlusion and central retinal vein occlusion. Several recent multicenter randomized clinical trials have been completed which have changed the approach to this disorder. Management of retinal vein occlusions can be directed at the underlying etiology or the resulting sequelae. Options include surgical intervention, laser photocoagulation, intravitreal pharmacotherapy, and sustained drug delivery devices.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21601903     DOI: 10.1016/j.survophthal.2010.11.006

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  47 in total

Review 1.  Use of bevacizumab for macular edema secondary to branch retinal vein occlusion: a systematic review.

Authors:  Taygan Yilmaz; Miguel Cordero-Coma
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-04-27       Impact factor: 3.117

Review 2.  Role of Lipids in Retinal Vascular and Macular Disorders.

Authors:  Gunjan Prakash; Rachit Agrawal; Tanie Natung
Journal:  Indian J Clin Biochem       Date:  2016-03-08

3.  FELLOW EYE CHANGES IN PATIENTS WITH NONISCHEMIC CENTRAL RETINAL VEIN OCCLUSION: Assessment of Perfused Foveal Microvascular Density and Identification of Nonperfused Capillaries.

Authors:  Alexander Pinhas; Michael Dubow; Nishit Shah; Eric Cheang; Chun L Liu; Moataz Razeen; Alexander Gan; Rishard Weitz; Yusufu N Sulai; Toco Y Chui; Alfredo Dubra; Richard B Rosen
Journal:  Retina       Date:  2015-10       Impact factor: 4.256

4.  Clinical Characteristics of Patients With CRVO in One Eye With Subsequent RVO in The Fellow Eye: A Retrospective Observational Study.

Authors:  Melissa Mei Hsia Chan; Akshay S Thomas; Stephen P Yoon; Diana Leitner; Sharon Fekrat
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2019-07-01       Impact factor: 1.300

5.  Outcome of "treat and monitor" regimen of aflibercept and ranibizumab in macular edema secondary to non-ischemic branch retinal vein occlusion.

Authors:  Francesco Pichi; Ahmed Mohammed Elbarky; Tarek Roshdy Elhamaky
Journal:  Int Ophthalmol       Date:  2017-12-22       Impact factor: 2.031

6.  Therapeutic potential of intravitreal pharmacotherapy in retinal vein occlusion.

Authors:  Marianne L Shahsuvaryan
Journal:  Int J Ophthalmol       Date:  2012-12-18       Impact factor: 1.779

7.  Fundus changes in branch retinal vein occlusion.

Authors:  Sohan Singh Hayreh; M Bridget Zimmerman
Journal:  Retina       Date:  2015-05       Impact factor: 4.256

8.  Comparison between ranibizumab and aflibercept for macular edema associated with central retinal vein occlusion.

Authors:  Yoshitsugu Saishin; Yuka Ito; Masato Fujikawa; Tomoko Sawada; Masahito Ohji
Journal:  Jpn J Ophthalmol       Date:  2016-09-22       Impact factor: 2.447

9.  Peripheral retinal non-perfusion and treatment response in branch retinal vein occlusion.

Authors:  Kaveh Abri Aghdam; Lukas Reznicek; Mostafa Soltan Sanjari; Carsten Framme; Anna Bajor; Annemarie Klingenstein; Marcus Kernt; Florian Seidensticker
Journal:  Int J Ophthalmol       Date:  2016-06-18       Impact factor: 1.779

10.  Choroidal Changes After Suprachoroidal Injection of Triamcinolone Acetonide in Eyes With Macular Edema Secondary to Retinal Vein Occlusion.

Authors:  Alex S Willoughby; Vivian S Vuong; David Cunefare; Sina Farsiu; Glenn Noronha; Ronald P Danis; Glenn Yiu
Journal:  Am J Ophthalmol       Date:  2017-12-02       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.